Bovitubal - 28 000 NE/ml szarvasmarha tuberkulin A.U.V.
Bovitubal - 28 000 NE/ml szarvasmarha tuberkulin A.U.V.
Authorised
- Mycobacterium bovis, strain AN5, bovine tuberculin purified protein derivative
Product identification
Medicine name:
Bovitubal - 28 000 NE/ml szarvasmarha tuberkulin A.U.V.
Active substance:
- Mycobacterium bovis, strain AN5, bovine tuberculin purified protein derivative
Target species:
-
Cattle
-
Sheep
-
Goat
-
Horse
-
Pig
-
Dog
Route of administration:
-
Intradermal use
Product details
Active substance and strength:
-
Mycobacterium bovis, strain AN5, bovine tuberculin purified protein derivative28000.00/international unit(s)1.00unit(s)/dose
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intradermal use
- Cattle
-
Meat and offal0day
-
- Sheep
-
Meat and offal0day
-
- Goat
-
Meat and offal0day
-
- Horse
-
Meat and offal0day
-
- Pig
-
Meat and offal0day
-
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QV04CF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Hungary
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Alpha-Vet Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
